Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caris Life Sciences (CAI) Net Income (2024 - 2025)

Caris Life Sciences has reported Net Income over the past 2 years, most recently at $82.0 million for Q4 2025.

  • Quarterly results put Net Income at $82.0 million for Q4 2025, up 321.82% from a year ago — trailing twelve months through Dec 2025 was -$2.5 million (changed N/A YoY), and the annual figure for FY2025 was -$68.1 million, up 75.85%.
  • Net Income for Q4 2025 was $82.0 million at Caris Life Sciences, up from $24.3 million in the prior quarter.
  • Over the last five years, Net Income for CAI hit a ceiling of $82.0 million in Q4 2025 and a floor of -$71.8 million in Q2 2025.